Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated

Upper gastrointestinal acute graft-versus-host disease is reported in approximately 30% of hematopoietic stem cell transplant recipients developing acute graft-versus-host disease. Currently classified as Grade II in consensus criteria, upper gastrointestinal acute graft-versus-host disease is often...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Haematologica
Main Authors: Nikiforow, Sarah, Wang, Tao, Hemmer, Michael, Spellman, Stephen, Akpek, Görgün, Antin, Joseph H., Choi, Sung Won, Inamoto, Yoshihiro, Khoury, Hanna J., MacMillan, Margaret, Marks, David I., Meehan, Ken, Nakasone, Hideki, Nishihori, Taiga, Olsson, Richard, Paczesny, Sophie, Przepiorka, Donna, Reddy, Vijay, Reshef, Ran, Schoemans, Hélène, Waller, Ned, Weisdorf, Daniel, Wirk, Baldeep, Horowitz, Mary, Alousi, Amin, Couriel, Daniel, Pidala, Joseph, Arora, Mukta, Cutler, Corey
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6165812/
https://ncbi.nlm.nih.gov/pubmed/30076185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.182550
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares